×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NCEL – newcelx ltd. - ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NCEL
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/12
07:00 am
ncel
NewcelX Announce Positive Results from International Collaborative Study Exploring Advanced Biomaterial Approaches for Stem Cell-Derived Islet Delivery in Type 1 Diabetes Without Immune Suppression
Low
Report
NewcelX Announce Positive Results from International Collaborative Study Exploring Advanced Biomaterial Approaches for Stem Cell-Derived Islet Delivery in Type 1 Diabetes Without Immune Suppression
1/5
07:00 am
ncel
NewcelX Appoints Dr. Julien Boisdron, a Swiss Big Pharma Leader in Diabetes Innovation, to Its Scientific Advisory Board
Medium
Report
NewcelX Appoints Dr. Julien Boisdron, a Swiss Big Pharma Leader in Diabetes Innovation, to Its Scientific Advisory Board
12/11
07:22 am
ncel
NewcelX Expands Intellectual Property Footprint with Publication of DOXA Patent Application in China [Yahoo! Finance]
High
Report
NewcelX Expands Intellectual Property Footprint with Publication of DOXA Patent Application in China [Yahoo! Finance]
12/11
07:00 am
ncel
NewcelX Expands Intellectual Property Footprint with Publication of DOXA Patent Application in China
High
Report
NewcelX Expands Intellectual Property Footprint with Publication of DOXA Patent Application in China
11/17
07:00 am
ncel
NewcelX Strengthens Scientific Advisory Board with Appointment of Jeremy Shefner, MD, PhD, Chief Medical Officer at the Barrow Neurological Institute
Neutral
Report
NewcelX Strengthens Scientific Advisory Board with Appointment of Jeremy Shefner, MD, PhD, Chief Medical Officer at the Barrow Neurological Institute
11/15
01:42 am
ncel
NLS Pharmaceutics (NASDAQ:NCEL) was downgraded by analysts at Wall Stree
Low
Report
NLS Pharmaceutics (NASDAQ:NCEL) was downgraded by analysts at Wall Stree
11/6
07:00 am
ncel
NewcelX Announces Scientific Leadership with the Head of Division of Medical Neurosciences at the Department of Neurology at Hadassah, Prof. Tamir Ben-Hur on Its Scientific Advisory Board
High
Report
NewcelX Announces Scientific Leadership with the Head of Division of Medical Neurosciences at the Department of Neurology at Hadassah, Prof. Tamir Ben-Hur on Its Scientific Advisory Board
11/4
07:00 am
ncel
NewcelX CEO Issues Letter to Shareholders
Medium
Report
NewcelX CEO Issues Letter to Shareholders
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/12
07:13 am
ncel
Form 6-K NewcelX Ltd. For: Jan 12
High
Report
Form 6-K NewcelX Ltd. For: Jan 12
1/5
07:20 am
ncel
Form 6-K NewcelX Ltd. For: Jan 05
Medium
Report
Form 6-K NewcelX Ltd. For: Jan 05
12/11
09:22 am
ncel
Form 6-K NewcelX Ltd. For: Dec 11
High
Report
Form 6-K NewcelX Ltd. For: Dec 11
11/20
04:16 pm
ncel
Form 6-K NewcelX Ltd. For: Nov 20
Medium
Report
Form 6-K NewcelX Ltd. For: Nov 20
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: